Sarclisa recommended for EU approval by CHMP to treat transplant-ineligible newly diagnosed multiple myeloma: Sanofi Ruchika Sharma17 Nov 2024 4:00 PM ISTParis: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a...
Sanofi Gets CDSCO Panel Nod to Study Venglustat Dr. Divya Colin13 Nov 2024 5:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, the Subject Expert...
Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis Ruchika Sharma7 Nov 2024 3:55 PM ISTParis: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in...
Sanofi Healthcare Gets CDSCO Panel Nod to Study Asthma Drug SAR443765 Dr. Divya Colin3 Nov 2024 5:15 PM ISTNew Delhi: The drug major Sanofi Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO panel approves Sanofi Healthcare's protocol amendment proposal to study SAR441566 Dr. Divya Colin1 Nov 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Sanofi gets CDSCO Panel nod to study Amlitelimab Dr. Divya Colin31 Oct 2024 5:30 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sanofi's Opella sale faces political backlash amid fears of drug shortages MD Bureau22 Oct 2024 10:15 AM ISTParis: French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund...
Sanofi, CD&R in exclusive talks over sale of USD17 billion Opella MD Bureau22 Oct 2024 10:00 AM ISTSanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024
Sanofi closes deal for consumer health unit Opella: Report MD Bureau21 Oct 2024 1:18 PM ISTThe breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the country
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Bidding war for Sanofi's Opella intensifies as PAI raises bid MD Bureau18 Oct 2024 9:45 AM ISTAll candidates had the same opportunity to submit their best offers within the process deadline, Sanofi said.
Novavax faces setback as USFDA halts COVID-Flu vaccine trial over nerve damage report MD Bureau17 Oct 2024 3:13 PM ISTNovavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor neuropathy.
